跳至主要内容
临床试验/NCT01427491
NCT01427491已完成3 期

A Prospective, Multi-center, Randomized, Comparative Clinical Study to Compare Aquacel® Ag vs. Mepilex® Border Ag to Manage Bioburden in Leg Ulcers.

ConvaTec Inc.6 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
ConvaTec Inc.
入组人数
18
试验地点
6
主要终点
Microbial load reduction

研究概览

简要总结

The purpose of this study is to compare the ability of Aquacel® Ag and Mepilex® Border Ag to manage bioburden in leg ulcers over a two week study period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or over
  • Willing and able to provide written informed consent
  • Leg ulcer will be of size ranging between 10 cm2 - 40 cm2 with moderate or heavy exudate
  • Leg ulcer will exhibit at least 2 of the 4 following clinical signs: pain between 2 dressing changes, peri-ulcer skin erythema, oedema, foul odour

排除标准

  • Known skin sensitivity to any component of the products being tested
  • Subjects who have had current local or systemic antibiotics and/or topical antimicrobials applied in the week prior to inclusion
  • Depth of ulcer classified as superficial (not involving dermis) or deep (exposing muscle and tendon)
  • Any other medical condition which, according to the investigator, justifies the subject's exclusion from the study
  • Participated in a clinical study within the past 30 days

结局指标

主要结局

Microbial load reduction

时间窗: Days 1 and 14

The relative reduction from baseline in microbial load (bio-burden) over a 2 week study period as measured by quantitative and qualitative microbiology methods.

次要结局

  • clinical evolution of the wound (presence of each of the selected clinical signs)(Days 1, 3, 7, 14)
  • Occurrence of adverse events(Day 1-14)

研究者

发起方
ConvaTec Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验